Guggenheim Capital LLC grew its stake in shares of STERIS plc (NYSE:STE – Free Report) by 16.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,005 shares of the medical equipment provider’s stock after purchasing an additional 845 shares during the period. Guggenheim Capital LLC’s holdings in STERIS were worth $1,149,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently made changes to their positions in STE. 1832 Asset Management L.P. acquired a new stake in shares of STERIS in the 1st quarter worth about $25,000. Delta Asset Management LLC TN acquired a new stake in shares of STERIS in the 4th quarter worth about $27,000. Ronald Blue Trust Inc. raised its holdings in shares of STERIS by 309.1% in the 1st quarter. Ronald Blue Trust Inc. now owns 180 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 136 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in shares of STERIS by 1,104.0% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 301 shares of the medical equipment provider’s stock worth $58,000 after acquiring an additional 276 shares during the last quarter. Finally, Asset Dedication LLC raised its holdings in shares of STERIS by 96.9% in the 1st quarter. Asset Dedication LLC now owns 321 shares of the medical equipment provider’s stock worth $62,000 after acquiring an additional 158 shares during the last quarter. Institutional investors and hedge funds own 92.91% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on STE shares. Morgan Stanley upped their target price on shares of STERIS from $206.00 to $225.00 and gave the stock an “equal weight” rating in a report on Thursday, August 3rd. StockNews.com began coverage on shares of STERIS in a report on Thursday, August 17th. They issued a “buy” rating on the stock. Piper Sandler increased their price objective on shares of STERIS from $197.00 to $200.00 in a research note on Friday, May 12th. KeyCorp increased their price objective on shares of STERIS from $254.00 to $258.00 and gave the company an “overweight” rating in a research note on Thursday, August 3rd. Finally, JMP Securities increased their price objective on shares of STERIS from $240.00 to $265.00 and gave the company a “market outperform” rating in a research note on Friday. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $239.60.
STERIS Trading Up 0.6 %
NYSE:STE opened at $230.87 on Friday. STERIS plc has a 52 week low of $159.21 and a 52 week high of $254.00. The firm has a 50-day moving average price of $225.79 and a two-hundred day moving average price of $205.02. The firm has a market cap of $22.81 billion, a price-to-earnings ratio of 189.24, a price-to-earnings-growth ratio of 2.38 and a beta of 0.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.42 and a current ratio of 2.29.
STERIS (NYSE:STE – Get Free Report) last released its earnings results on Tuesday, August 1st. The medical equipment provider reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.14. STERIS had a net margin of 2.35% and a return on equity of 13.75%. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the prior year, the firm earned $1.90 EPS. The company’s revenue was up 11.1% compared to the same quarter last year. On average, equities analysts expect that STERIS plc will post 8.72 earnings per share for the current fiscal year.
STERIS Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Wednesday, September 6th will be given a dividend of $0.52 per share. This is an increase from STERIS’s previous quarterly dividend of $0.47. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Tuesday, September 5th. STERIS’s dividend payout ratio is currently 170.49%.
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
- Five stocks we like better than STERIS
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 8/28 – 9/1
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What are stock market earnings reports?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.